SSTR2 and hepatocellular carcinoma: The variability in staining intensity observed across different patient samples suggests heterogeneous SSTR2 expression within HCC, which may have implications for stratifying patients for targeted therapies and for understanding tumor biology in subgroups with high SSTR2 expression.